The closing price of Athira Pharma Inc (NASDAQ: ATHA) was $2.91 for the day, down -18.72% from the previous closing price of $3.58. In other words, the price has decreased by -$0.6700 from its previous closing price. On the day, 1147269 shares were traded.
Ratios:
Our analysis of ATHA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.37 and its Current Ratio is at 5.37. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On July 07, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $6.
Stifel Downgraded its Buy to Hold on June 23, 2022, whereas the target price for the stock was revised from $36 to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 05 ’24 when Litton Mark James sold 4,820 shares for $2.91 per share. The transaction valued at 14,026 led to the insider holds 144,397 shares of the business.
Worthington Mark sold 2,412 shares of ATHA for $7,019 on Jan 05 ’24. The General Counsel now owns 34,452 shares after completing the transaction at $2.91 per share. On Jan 05 ’24, another insider, Lenington Rachel, who serves as the Chief Operating Officer of the company, sold 2,412 shares for $2.91 each. As a result, the insider received 7,019 and left with 13,395 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATHA now has a Market Capitalization of 137.21M and an Enterprise Value of -8.62M.
Stock Price History:
Over the past 52 weeks, ATHA has reached a high of $4.30, while it has fallen to a 52-week low of $1.33. The 50-Day Moving Average of the stock is 3.2953, while the 200-Day Moving Average is calculated to be 2.5578.
Shares Statistics:
ATHA traded an average of 387.11K shares per day over the past three months and 486.52k shares per day over the past ten days. A total of 38.17M shares are outstanding, with a floating share count of 35.32M. Insiders hold about 7.84% of the company’s shares, while institutions hold 56.99% stake in the company. Shares short for ATHA as of Feb 15, 2024 were 650.33k with a Short Ratio of 1.68, compared to 513.85k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.70% and a Short% of Float of 2.33%.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.79 for the current quarter, with a high estimate of -$0.73 and a low estimate of -$0.86, while EPS last year was -$0.73. The consensus estimate for the next quarter is -$0.79, with high estimates of -$0.74 and low estimates of -$0.88.
Analysts are recommending an EPS of between -$3.01 and -$3.54 for the fiscal current year, implying an average EPS of -$3.24. EPS for the following year is -$1.97, with 4 analysts recommending between -$0.64 and -$3.58.
